Opportunity Alert – AC-160105-085 – TARGET HEALTH
AND THEIR REVIEW.
Date Sourced: March 22, 2016
Category: Options: Customer Opportunity
Status: Options: Active Discussion
Potential (High-Moderate-Low): Options: High
Add to SFA (Y/N): Options: Yes
Client Action Required (Y/N): Options: No
Opportunity:
Target Health Inc., is a full-service e*CRO committed to improving the way
companies run clinical trials. They have successfully used Target e*CRF in
over 300 clinical trials. The company leverages industry knowledge,
experience, technology and connectivity to streamline how companies run
studies. Website: Target
Health
Summary of Activities/Tasks:
1. March 22, 2016 – Met with Target Health President, Jules Mitchel during
the Clinical Trials Collaboration conference in Cambridge, MA. Discussed at
length the opportunity to support CROs and pharma with transformative,
virtual trial enabling software and devices. Jules is in DC next week –
coordinating time to meet.
2. April 11, 2016 – Jules is hosting the Clinical Trials Transformation
Summit in Rockville, MD. We met privately from 2:30-4:30pm. There is an
immediate opportunity with a major pharma company (Pfizer). They have
specifically contact Jules asking for remote subject monitoring solutions
in conjunction with their eCRF trial software. CleverCap is a great fit and
the proposal opportunity is immediate.
Forward Statements and Guidance:
A collaboration strategy is currently being outlined that would enable
Target Health and CleverCap to co-pursue pharma clients (est. 4/14/16). Ron
will be meeting with the Target Health management team in NYC on 4/28/16.
Discussions will include both the pharma requested RPM proposal with
CleverCap; and potential ongoing joint pharma customer pursuit
collaboration.
End.
Return to Listing
COMMENT FORM.
Comments
Facilitator
The following list of contacts/organizations that Patriot Labs has been speaking with regarding the use of CleverCap in clinical trials was shared with Target Health to better coordinate joint proposal efforts.
Amir Kalali – Quintiles, Global Head, Neuroscience Center of Excellence
Alan Metz – Quintiles, SVP Strategic Partnerships and Alliances
Judy Dunn – Roche, Head of Operations, Early Development
Mark Matson – Covance, Director of Bus Dev Phase II – IV
Atul Mahableshwarkar – Takeda Global R&D, Senior Medical Director
Ron Marcus – Cerecor, Chief Medical Officer, Head, Regulatory Affairs
Heather Bryson – PPD, Sr Clinical Business Mgmt Dir, Global Product Development
Facilitator
Preparing joint proposals for Amgen, Lilly, and BMS.
Facilitator
Meeting confirmed: To be held at Target Health NYC corporate offices on March 29 at 1pm ET.